Related Experiment Video
Updated: Jul 11, 2026
08:47
Spectral Confocal Imaging of Fluorescently tagged Nicotinic Receptors in Knock-in Mice with Chronic Nicotine Administration
Published on: February 10, 2012
Met receptor dynamics and signalling.
D E Hammond1, S Carter, M J Clague
1Physiological Laboratory, University of Liverpool, Liverpool, UK.
Current Topics in Microbiology and Immunology
|January 14, 2005
Summary
Met receptor downregulation is crucial for controlling cell growth and preventing cancer. Defects in Met receptor trafficking and degradation can lead to cell transformation and cancer progression.
Area of Science:
- Cell Biology
- Molecular Oncology
- Signal Transduction
Background:
- The hepatocyte growth factor (HGF) receptor, Met, regulates invasive growth, proliferation, and morphogenesis, essential for development and regeneration.
- Dysregulation of Met signaling is implicated in cancer progression and metastasis.
- Met receptor downregulation via endocytosis and proteasome degradation is a key regulatory mechanism.
Purpose of the Study:
- To investigate the role of Met receptor trafficking and degradation in cellular transformation.
- To explore the link between Met endosomal trafficking defects and cancer-associated mutations.
Main Methods:
- Studied Met receptor downregulation in tissue culture cells upon HGF stimulation.
- Investigated the involvement of endocytic pathways and proteasome activity in Met degradation.
- Analyzed the role of E3-ligase Cbl in Met ubiquitination and downregulation.
- Examined the functional consequences of a Met receptor mutant defective in Cbl binding.
Main Results:
- Acute HGF stimulation induces Met downregulation through an endocytic mechanism requiring proteasome activity.
- Perturbing Met trafficking at internalization or early endosome sorting alters signaling.
- Met ubiquitination by Cbl is essential for receptor downregulation; Cbl-binding deficient mutants transform cells.
- Naturally occurring Met mutants in cancer may transform cells due to impaired endosomal degradation.
Conclusions:
- Met receptor trafficking and degradation are critical for controlling cell growth and preventing oncogenic transformation.
- Defects in the Met endosomal degradation pathway, particularly involving Cbl, can lead to cellular transformation and contribute to cancer progression.
- Targeting Met trafficking pathways may offer novel therapeutic strategies for cancers driven by Met dysregulation.
More Related Videos
Related Concept Videos
01:26Signal Transduction: Overview
Cells respond to many types of information, often through receptor proteins positioned on the membrane. They respond to chemical signals, such as hormones, neurotransmitters, and other signaling molecules, initiating a series of molecular reactions to produce an appropriate response. This is called signal transduction. Cells also coordinate different responses elicited by the same signaling molecule via mediators, allowing molecular cross-talk.
Typically, signal transduction involves three...
Typically, signal transduction involves three...
01:31Transducer Mechanism: Nuclear Receptors
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
01:29The Two-State Receptor Model
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with one...
The binding affinity of a drug determines its interaction with one...
01:25Cholinergic Receptors: Muscarinic
The pharmacological actions of acetylcholine are elicited via its binding to two families of cholinergic receptors or cholinoceptors, namely, muscarinic and nicotinic receptors. Muscarinic receptors are G protein-coupled receptors and have five subtypes, M1–M5. All mAChR subtypes are activated by acetylcholine and blocked by the antagonist, atropine.
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+. Activation...
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+. Activation...
01:15Cholinergic Receptors: Nicotinic
Nicotinic receptors are ligand-gated ion channels that are activated by acetylcholine and nicotine. Upon activation, they cause a rapid increase in the permeability of cells to K+, Na+, and Ca2+, followed by depolarization and excitation. They are in the autonomic ganglia, skeletal neuromuscular junction, CNS, and adrenal medulla.
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
01:23Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...